[A case report of coronary artery bypass grafting surgery with aprotinin in a patient undergoing chronic haemodialysis].
A 61-year-old patient who was receiving haemodialysis because of chronic renal failure developed unstable angina pectoris with three vessel disease. We performed successful coronary artery bypass grafting, using aprotinin to reduce blood loss. Blood loss during the operation was 750 ml, and during a 6 hour period after the operation it was 150 ml. This amount seemed to be small. No adverse clinical effects attributable to aprotinin were seen, and urine volume and plasma creatinine were not different before and after the operation. In summary, aprotinin is useful adjunct to open heart surgery in chronic haemodialysis patients.
Ueyama
K
K
Department of Cardiovascular Surgery, Fukui Cardiovascular Center, Japan.
Ohashi
H
H
Tsutsumi
Y
Y
Murakami
A
A
Fukahara
K
K
Fujii
S
S
Abe
Y
Y
Ohnaka
M
M
D007611:Aprotinin / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000150:complications / Q000601:surgery*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
D007611:Aprotinin